Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.47 |
| ▸ | HPGD | P15428 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.46 |
| ▸ | ESR1 | P03372 | 2/20 | 0.45 |
| ▸ | ADRA2A | P08913 | 2/20 | 0.45 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.45 |
| ▸ | TACR2 | P21452 | 2/20 | 0.45 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.45 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.45 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | SHBG | P04278 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | HSPD1 | P10809 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9720081 | 0.94 | ESR1 (0.53) | CA2ALDH1A1HSD17B10ESR1ADRA2A | |
| SCHEMBL4882552 | 0.92 | PTGS2 (0.57) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL15302863 | 0.92 | PTGS2 (0.57) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL10426156 | 0.92 | PTGS2 (0.57) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL18281616 | 0.92 | PTGS2 (0.57) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL2561141 | 0.92 | PTGS2 (0.57) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 | |
| SCHEMBL10482087 | 0.88 | RARB (0.53) | ALDH1A1HSD17B10HPGDSMN1; SMN2ESR1 | |
| SCHEMBL10528133 | 0.87 | HSD17B10 (0.56) | ALDH1A1HSD17B10HPGDSMN1; SMN2ESR1 | |
| SCHEMBL3044257 | 0.86 | LPL (0.45) | CA2ALDH1A1KDM4EPLK1LPL | |
| SCHEMBL10571328 | 0.86 | MAOB (0.39) | ALDH1A1HSD17B10ESR1ADRA2AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12637475-B2 | Method for producing naphthylsilole, naphthylsilole containing heterocyclic group, and graphene nanoribbon containing heterocyclic group | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2026-05-26 | — | — | US | disclosed |
| EP-4116308-B1 | METHOD FOR PRODUCING NAPHTYLSILOLE, NAPHTHYLSILOLE CONTAINING HETEROCYCLIC GROUP, AND GRAPHENE NANORIBBON CONTAINING HETEROCYCLIC GROUP | NATIONAL UNIV CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2026-05-13 | — | — | EP | disclosed |
| US-20230121865-A1 | METHOD FOR PRODUCING NAPHTHYLSILOLE, NAPHTHYLSILOLE CONTAINING HETEROCYCLIC GROUP, AND GRAPHENE NANORIBBON CONTAINING HETEROCYCLIC GROUP | NATIONAL UNIVERSITY CORPORATION TOKAI NATIONAL HIGHER EDUCATION AND RESEARCH SYSTEM (JP) | 2023-04-20 | — | — | US | disclosed |
| EP-4116308-A1 | NAPHTHYL SILOLE PRODUCTION METHOD, NAPHTHYL SILOLE HAVING HETEROCYCLIC GROUP, AND GRAPHENE NANORIBBONS HAVING HETEROCYCLIC GROUP | National University Corporation Tokai National Higher Education and Research System (JP) | 2023-01-11 | — | — | EP | disclosed |
| EP-3940013-A1 | GRAPHENE NANORIBBON AND METHOD FOR PRODUCING SAME | Taoka Chemical Co., Ltd. (JP) | 2022-01-19 | — | — | EP | disclosed |
| CN-113677731-A | Graphene nanoribbons and methods of making the same | 田冈化学工业株式会社 | 2021-11-19 | — | — | CN | disclosed |
| WO-2020184625-A1 | GRAPHENE NANORIBBON AND METHOD FOR PRODUCING SAME | 国立大学法人東海国立大学機構 | 2020-09-17 | — | — | WO | disclosed |
| EP-2234973-B1 | ANTHELMINTIC AGENTS AND THEIR USE | INTERVET INT BV (NL) | 2014-07-02 | — | — | EP | disclosed |
| US-8569495-B2 | Anthelmintic agents and their use | INTERVET INTERNATIONAL B.V. (NL) | 2013-10-29 | — | — | US | disclosed |
| US-8097644-B2 | Indole compounds having sphingosine-1-phosphate (S1P) receptor antagonist | ALLERGAN, INC. (US) | 2012-01-17 | — | — | US | disclosed |
| EP-1856010-A1 | METHODS FOR OLIGOMERIZING OLEFINS | Exxonmobil Chemical Patents Inc. (US) | 2007-11-21 | — | — | EP | disclosed |
| US-20070232682-A1 | Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist | ALLERGAN, INC. (US) | 2007-10-04 | — | — | US | disclosed |
| EP-1618094-B1 | SUBSTITUTED HETEROARYLS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | INST FOR PHARM DISCOVERY INC (US) | 2007-09-05 | — | — | EP | disclosed |
| US-20060247399-A1 | Methods for oligomerizing olefins | EXXONMOBIL CHEMICAL PATENTS INC. | 2006-11-02 | — | — | US | disclosed |
| WO-2006099053-A1 | METHODS FOR OLIGOMERIZING OLEFINS | EXXONMOBIL CHEMICAL PATENTS INC. (US) | 2006-09-21 | — | — | WO | disclosed |
| EP-1618094-A1 | SUBSTITUTED HETEROARYLS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | The Institutes for Pharmaceutical Discovery, LLC (US) | 2006-01-25 | — | — | EP | disclosed |
| US-20050009817-A1 | Substituted heteroaryls | INSTITUTES FOR PHARMACEUTICAL DISCOVERY, L.L.C. | 2005-01-13 | — | — | US | disclosed |
| WO-2004099159-A1 | SUBSTITUTED HETEROARYLS AS INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES | THE INSTITUTES FOR PHARMACEUTICAL DISCOVERY, LLC (US) | 2004-11-18 | — | — | WO | disclosed |
| US-6096894-A | Production method of 2-(p-alkylphenyl)pyridine compound | SUMIKA FINE CHEMICALS CO., LTD. (JP) | 2000-08-01 | — | — | US | disclosed |
| EP-0976736-A1 | Production method of 2-(p-alkylphenyl)pyridine compound | SUMIKA FINE CHEMICALS Co., Ltd. (JP) | 2000-02-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070232682-A1 | Indole Compounds having sphingosine-1-phosphate (S1P) receptor antagonist | S1PR1, S1PR2, S1PR3 | CA2 2068/4885CA1 4744/4885ALDH1A1 2262/4885 |
| US-20050009817-A1 | Substituted heteroaryls | PTPRS, PTPRO, PTPRR | CA2 4281/4885CA1 4632/4885ALDH1A1 477/4885 |
| US-20230121865-A1 | METHOD FOR PRODUCING NAPHTHYLSILOLE, NAPHTHYLSILOLE CONTAINING HETEROCYCLIC GROUP, AND GRAPHENE NANORIBBON CONTAINING HETEROCYCLIC GROUP | C1R, INSR, CCKBR | CA2 3255/4885CA1 2660/4885ALDH1A1 2786/4885 |
| US-12637475-B2 | Method for producing naphthylsilole, naphthylsilole containing heterocyclic group, and graphene nanoribbon containing heterocyclic group | LBR, INSR, IGF1R | CA2 2449/4885CA1 1947/4885ALDH1A1 2171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.